πŸ‡ΊπŸ‡Έ FDA
Patent

US 11793812

Methods of treating endometriosis

granted A61KA61K31/513A61K31/519

Quick answer

US patent 11793812 (Methods of treating endometriosis) held by Takeda Pharmaceutical Company Limited expires Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Oct 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K31/513, A61K31/519, A61K31/565, A61K31/57